|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn893913515 |
003 |
OCoLC |
005 |
20231120111844.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
141028s1981 nyua ob 001 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d E7B
|d N$T
|d OCLCF
|d EBLCP
|d HEBIS
|d OCLCQ
|d OCLCO
|d YDXCP
|d OCLCQ
|d VLY
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 896796169
|a 948660744
|a 1162043378
|
020 |
|
|
|a 9781483267906
|q (electronic bk.)
|
020 |
|
|
|a 1483267903
|q (electronic bk.)
|
020 |
|
|
|z 9780121978020
|
020 |
|
|
|z 0121978028
|
035 |
|
|
|a (OCoLC)893913515
|z (OCoLC)896796169
|z (OCoLC)948660744
|z (OCoLC)1162043378
|
050 |
|
4 |
|a RC271.C5
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.994061
|2 22
|
245 |
0 |
0 |
|a Cancer and chemotherapy.
|n Volume II,
|p Introduction to clinical oncology /
|c edited by Stanley T. Crooke and Archie W. Prestayko.
|
246 |
3 |
0 |
|a Introduction to clinical oncology
|
264 |
|
1 |
|a New York :
|b Academic Press,
|c 1981.
|
300 |
|
|
|a 1 online resource (380 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Introduction to Clinical Oncology; Copyright Page; Table of Contents; LIST OF CONTRIBUTORS; GENERAL PREFACE; PREFACE TO VOLUME II; Part I: Leukemias and Lymphomas; CHAPTER 1. THE ACUTE LEUKEMIAS; I. INTRODUCTION; II. INCIDENCE; III. CLASSIFICATION; IV. PREDISPOSING FACTORS; V. PRESENTING FEATURES; VI. DIFFERENTIAL DIAGNOSIS; VII. LABORATOvbRY FEATURES; VIII. GENERAL THERAPEUTIC CONSIDERATIONS; IX. GENERAL CLINICAL CONSIDERATIONS; X. PROGNOSTIC FACTORS; XI. CONCLUSIONS; ACKNOWLEDGMENTS; REFERENCES; CHAPTER 2. HAIRY CELL LEUKEMIA; I. DEFINITION; II. INCIDENCE WITH AGE AND SEX RATIO.
|
505 |
8 |
|
|a III. PATHOLOGYIV. PATHOGENESIS; V. CLINICAL FEATURES; VI. LABORAfgTORY FEATURES; VII. TREATMENT; VIII. COURSE OF DISEASE; IX. SUMMARY; REFERENCES; CHAPTER 3. CHRONIC LYMPHOCYTIC LEUKEMIA; I. DEFINITION; II. EPIDEMIOLOGY; III. ETIOLOGIC FEATURES; IV. PATHOLOGIC OBSERVATIONS; V. PATHOGENESIS; VI. CLINICAL FEATURES; VII. LABORATORY FEATURES; VIII. DIFFERENTIAL DIAGNOSIS; IX. TREATMENT; X. PROGNOSTIC FACTORS; XI. COURSE OF DISEASE; REFERENCES; CHAPTER 4. CHRONfghIC MYELOCYTIC LEUKEMIA; I. SPECIAL CHARACTERISTICS; II. CLINICAL FEATURES; III. CLINICAL COURSE; IV. SUMMARY AND CONCLUSIONS.
|
505 |
8 |
|
|a ACKNOWLEDGMENTSREFERENCES; CHAPTER 5. THE LYMPHOMAS; I. INTRODUCTION; II. HODGKIN'S DISEASE; III. NON-HODGKIN'S LYMPHOMAS; IV. CONCLUSION; ACKNOWLEDGMENT; REFERENCES; Part II: Solid Tumors; CHAPTER 6. CARCINOMA OF THE BREAST; I. INTRODUCTION; II. INCIDENCE AND CAUSATIVE FACTORS; III. PATHOLOGY; IV. CLINICAL PRESENTATION; V. PROGNOSTIC FEATURES; VI. CLINICAL COURSE OF METASTATIC BREAST CANCER; VII. SURGICAL THERAPY; VIII. RADIATION THERAPY; IX. HORMONAL THERAPY; X. CHEMOTHERAPY; XI. DISCUSSION; REFERENCES; CHAPTER 7. CLINICAL PRESENTATIONS OF GASTROINTESTINAL CANCER; I. LARGE-BOWEL CARCINOMA.
|
505 |
8 |
|
|a Ii. carcinoma of the pancreasiii. carcinoma of the stomach; references; chapter 8. cancers of the head and neck; i. introduction; ii. incidence; iii. etiology; iv. histopathology and spread; v. clinical manifestations; vi. diagnosis; vii. clinical staging; viii. management; ix. conclusions; acknowledgement; references; chapter 9. carcinoma of the lung; i. introduction; ii. classification; iii. evaluation of lung cancer; iv. management of non-small cell anaplastic cancer; v. management of metastatic non small-cell anaplastic lung cancer.
|
505 |
8 |
|
|a VI. EVALUATION AND MANAGEMENT OF SMALL-CELL ANAPLASTIC CARCINOMAVII. CONCLUSION; REFERENCES; CHAPTER 10. CLINICAL CHARACTERISTICS OF CANCER IN THE BRAIN AND SPINAL CORD; I. INTRODUCTION; II. TUMORS OF THE BRAIN; III. MENINGEAL CARCINOMATOSIS; IV. TUMORS OF THE SPINAL CORD; ACKNOWLEDGMENTS; REFERENCES; CHAPTER 11. GENITOURINARY CANCER; I. INTRODUCTION; II. RENAL CARCINOMA; III. CARCINOMA OF THE RENAL PELVIS; IV. CARCINOMA OF THE URETER; V. FEMALE URETHRAL CARCINOMA; VI. MALE URETHxfdydRAL CARCINOMA; VII. PENILE CARCINOMA; VIII. TESTICULAR TUMORS; IX. BLADDER CANCER; X. PROSTATE CANCER.
|
520 |
|
|
|a Introduction to Clinical Oncology.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Antineoplastic agents.
|
650 |
|
0 |
|a Tumors
|x Chemotherapy.
|
650 |
|
0 |
|a Antimitotic agents.
|
650 |
|
2 |
|a Neoplasms
|x drug therapy
|0 (DNLM)D009369Q000188
|
650 |
|
2 |
|a Antineoplastic Agents
|0 (DNLM)D000970
|
650 |
|
2 |
|a Antimitotic Agents
|0 (DNLM)D050256
|
650 |
|
6 |
|a Anticanc�ereux.
|0 (CaQQLa)201-0004692
|
650 |
|
6 |
|a Tumeurs
|0 (CaQQLa)201-0079779
|x Chimioth�erapie.
|0 (CaQQLa)201-0379519
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Antimitotic agents
|2 fast
|0 (OCoLC)fst00810570
|
650 |
|
7 |
|a Antineoplastic agents
|2 fast
|0 (OCoLC)fst00810595
|
650 |
|
7 |
|a Tumors
|x Chemotherapy
|2 fast
|0 (OCoLC)fst01158763
|
700 |
1 |
|
|a Crooke, Stanley T.,
|e editor.
|
700 |
1 |
|
|a Prestayko, Archie W.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Introduction to clinical oncology
|z 9781483267906
|w (OCoLC)11101536
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780121978020
|z Texto completo
|